Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: Clin Cancer Res. 2008 Oct 15;14(20):6640–6646. doi: 10.1158/1078-0432.CCR-07-4681

Figure 1. Kaplan-Meier survival curves beyond 12 months by genotype for IL4R SNPs among high-grade gliomas.

Figure 1

(A) Patients with the TT genotype for IL4R rs1805016 SNP experienced a median survival 4 months longer than those with the GT/GG genotypes. (B) Patients with the TT genotype for IL4R rs1805015 SNP experienced a median survival of 5 months longer than those with the CT/CC genotypes. The benefit of the TT genotypes seemed to increase as the patients lived longer.